Literature DB >> 25550824

Increased activity of Rho kinase contributes to hemoglobin-induced early disruption of the blood-brain barrier in vivo after the occurrence of intracerebral hemorrhage.

Zhenghao Fu1, Yizhao Chen2, Fengzhen Qin3, Shuo Yang4, Xinqing Deng5, Rui Ding2, Liang Feng2, Weiguang Li6, Jianfeng Zhu6.   

Abstract

This study is to examine whether the activation of Rho kinase (ROCK) accounts for hemoglobin (Hb)-induced disruption of blood-brain barrier (BBB) after the occurrence of intracerebral hemorrhage. A model of intracerebral injection of Hb was established in rats. Changes in the levels of mRNA of RhoA, ROCK2 and matrix metalloproteinase-9 (MMP-9) were measured using quantitative real-time polymerase chain reaction. Protein expression of RhoA, ROCK2, claudin-5 and MMP-9, as well as ROCK activity, were determined using Western blotting. Immunohistochemical assay was performed to visualize the expression of RhoA, ROCK2, claudin-5 and MMP-9 in endothelial cells. Hb injection produced a significant increase in BBB permeability and water content in the brain. Significant reduction of claudin-5 expression was detected by Western blotting and immunofluorescence in Hb group. The levels of RhoA and ROCK2 were significantly up-regulated from 6 h to 12 h after Hb injection and were concomitant with the increase in ROCK activity. Immunofluorescence double staining showed enhanced p-myosin light chain immunoreactivity but diminished claudin-5 staining in endothelial cells. Significant up-regulation of MMP-9 expression was detected after Hb injection, and statistical analyses further confirmed a positive correlation of MMP-9 expression with ROCK activity. The results showed that ROCK was activated in endothelial cells by Hb. This may account for the early disruption of the BBB via up-regulation of p-myosin light chain expression and aggravation of injuries to TJ proteins. The activation of ROCK may also increase MMP-9 expression, thereby leading to further BBB disruption.

Entities:  

Keywords:  Blood-brain barrier; Rho kinase; hemoglobin; intracerebral hemorrhage; matrix metalloproteinase; tight junction

Mesh:

Substances:

Year:  2014        PMID: 25550824      PMCID: PMC4270524     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  Mechanisms of brain injury after intracerebral haemorrhage.

Authors:  Guohua Xi; Richard F Keep; Julian T Hoff
Journal:  Lancet Neurol       Date:  2006-01       Impact factor: 44.182

2.  Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.

Authors:  Neil A Turner; David J O'Regan; Stephen G Ball; Karen E Porter
Journal:  FASEB J       Date:  2005-02-23       Impact factor: 5.191

3.  Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms.

Authors:  T Hirase; S Kawashima; E Y Wong; T Ueyama; Y Rikitake; S Tsukita; M Yokoyama; J M Staddon
Journal:  J Biol Chem       Date:  2001-01-03       Impact factor: 5.157

4.  Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.

Authors:  Yi Yang; Eduardo Y Estrada; Jeffrey F Thompson; Wenlan Liu; Gary A Rosenberg
Journal:  J Cereb Blood Flow Metab       Date:  2006-07-19       Impact factor: 6.200

5.  Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats.

Authors:  Mutsumi Fujii; Kamil Duris; Orhan Altay; Yoshiteru Soejima; Prativa Sherchan; John H Zhang
Journal:  Neurochem Int       Date:  2011-12-30       Impact factor: 3.921

6.  Hemoglobin-induced nitric oxide synthase overexpression and nitric oxide production contribute to blood-brain barrier disruption in the rat.

Authors:  Shuo Yang; Yizhao Chen; Xinqing Deng; Weiping Jiang; Bing Li; Zhenghao Fu; Mouxuan Du; Rui Ding
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

7.  The cellular reactions to experimental intracerebral hemorrhage.

Authors:  A H Koeppen; A C Dickson; J A McEvoy
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

8.  Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE).

Authors:  Yuri Persidsky; David Heilman; James Haorah; Marina Zelivyanskaya; Raisa Persidsky; Gregory A Weber; Hiroaki Shimokawa; Kozo Kaibuchi; Tsuneya Ikezu
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

9.  Poly(ADP-ribose) polymerase activation and brain edema formation by hemoglobin after intracerebral hemorrhage in rats.

Authors:  X Bao; G Wu; S Hu; F Huang
Journal:  Acta Neurochir Suppl       Date:  2008

Review 10.  Tight junctions and the modulation of barrier function in disease.

Authors:  Carola Förster
Journal:  Histochem Cell Biol       Date:  2008-04-16       Impact factor: 4.304

View more
  12 in total

Review 1.  Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets.

Authors:  Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-08       Impact factor: 6.200

2.  Inhibition of stress fiber formation preserves blood-brain barrier after intracerebral hemorrhage in mice.

Authors:  Anatol Manaenko; Peng Yang; Derek Nowrangi; Enkhjargal Budbazar; Richard E Hartman; Andre Obenaus; William J Pearce; John H Zhang; Jiping Tang
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-19       Impact factor: 6.200

Review 3.  Application of stem cells and exosomes in the treatment of intracerebral hemorrhage: an update.

Authors:  Jian-Feng Zhou; Yu Xiong; Xiaodong Kang; Zhigang Pan; Qiangbin Zhu; Roland Goldbrunner; Lampis Stavrinou; Shu Lin; Weipeng Hu; Feng Zheng; Pantelis Stavrinou
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

4.  Spreading depolarizations trigger caveolin-1-dependent endothelial transcytosis.

Authors:  Homa Sadeghian; Baptiste Lacoste; Tao Qin; Xavier Toussay; Roberto Rosa; Fumiaki Oka; David Y Chung; Tsubasa Takizawa; Chenghua Gu; Cenk Ayata
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

5.  Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury.

Authors:  Xiaoning Han; Xi Lan; Qiang Li; Yufeng Gao; Wei Zhu; Tian Cheng; Takayuki Maruyama; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

6.  Toxic effects of cell-free hemoglobin on the microvascular endothelium: implications for pulmonary and nonpulmonary organ dysfunction.

Authors:  Jamie E Meegan; Julie A Bastarache; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

7.  Cell-free hemoglobin-mediated human lung microvascular endothelial barrier dysfunction is not mediated by cell death.

Authors:  Toria Tomasek; Lorraine B Ware; Julie A Bastarache; Jamie E Meegan
Journal:  Biochem Biophys Res Commun       Date:  2021-04-10       Impact factor: 3.322

8.  P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats.

Authors:  Hengli Zhao; Xuan Zhang; Zhiqiang Dai; Yang Feng; Qiang Li; John H Zhang; Xin Liu; Yujie Chen; Hua Feng
Journal:  Sci Rep       Date:  2016-03-16       Impact factor: 4.379

9.  Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.

Authors:  Be'eri Niego; Natasha Lee; Pia Larsson; T Michael De Silva; Amanda E-Ling Au; Fiona McCutcheon; Robert L Medcalf
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

10.  TRPV4 Blockade Preserves the Blood-Brain Barrier by Inhibiting Stress Fiber Formation in a Rat Model of Intracerebral Hemorrhage.

Authors:  Hengli Zhao; Kaiyuan Zhang; Rongrui Tang; Hui Meng; Yongjie Zou; Pengfei Wu; Rong Hu; Xin Liu; Hua Feng; Yujie Chen
Journal:  Front Mol Neurosci       Date:  2018-03-27       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.